Insulin resistance in chronic kidney disease: a systematic review (Q30244271)

12 June 2017

1 reference

1 reference

title

Insulin resistance in chronic kidney disease: a systematic review (English)

1 reference

chronic renal insufficiency

12 June 2017

1 reference

1 reference

1 reference

1 reference

3

Carmine Zoccali

1 reference

12 June 2017

Belinda Spoto

1

1 reference

12 June 2017

Anna Pisano

series ordinal

2

1 reference

12 June 2017

publication date

5 October 2016

1 reference

American Journal of Physiology - Renal Physiology

12 June 2017

published in

1 reference

12 June 2017

volume

311

1 reference

12 June 2017

issue

6

1 reference

12 June 2017

page(s)

F1087-F1108

1 reference

Comparison of insulin resistance in the various stages of chronic kidney disease and inflammation

12 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and altered glucose transporter 4 expression in experimental uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Glucose-induced insulin secretion in uremia: relation with acid-base balance and effects of bicarbonate administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Colonic contribution to uremic solutes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin stimulates volume absorption in the rabbit proximal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin signalling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Relationship between insulin resistance and inflamation markers in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and risk of chronic kidney disease in nondiabetic US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Glucose metabolism in muscle of sedentary and exercised rats with azotemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance, cystatin C, and mortality among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Pragmatic Clinical Trials in CKD: Opportunities and Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The effects of glucose and insulin on renal electrolyte transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Body composition analysis by bioelectrical impedance in chronic maintenance dialysis patients: comparisons to the National Health and Nutrition Examination Survey III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The prevalence of insulin resistance in kidney disease patients before the development of renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin release from pancreatic islets: effects of CRF and excess PTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Visceral adipose tissue is associated with insulin resistance in hemodialyzed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in chronic uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance is not independently associated with chronic kidney disease in Chinese population: A population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Physical activity levels in patients on hemodialysis and healthy sedentary controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Human uremic plasma and not urea induces exuberant secretion of leptin in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and left ventricular mass in non-diabetic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The effect of insulin on the heart : Part 1: Effects on metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

p-Cresyl sulfate promotes insulin resistance associated with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Correlates of insulin resistance in older individuals with and without kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Exercise performance falls over time in patients with chronic kidney disease despite maintenance of hemoglobin concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Threading analysis suggests that the obese gene product may be a helical cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Metabolic effects of erythropoietin in patients on peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Low pH accelerates dissociation of receptor-bound insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Induction of insulin resistance in normal adipose tissue by uremic human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Is there a link between insulin resistance and chronic kidney disease in men with treated hypertension? Analysis of 5-year data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Circulating omentin concentration increases after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Cardiovascular actions of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Chronic kidney disease, insulin resistance, and incident diabetes in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Parameters derived by ultrasonic myocardial characterization in dialysis patients are associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Tumor necrosis factor-alpha modulates human in vivo lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The renal metabolism of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Arterial stiffness in predialysis patients with uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Modification of Glucose-Induced Insulin Release by Alteration of pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance in adult polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Chronic kidney disease alters intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Indoxyl Sulfate–Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Association between insulin resistance and carotid arterial stiffness in nondiabetic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00340.2016

Simultaneous analysis of anthocyanin and non-anthocyanin flavonoid in various tissues of different lotus (Nelumbo) cultivars by HPLC-DAD-ESI-MS(n)

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0062291

Identifiers

DOI

10.1152/AJPRENAL.00340.2016

1 reference

12 June 2017

1 reference